NAYA Biosciences, Inc (NAYA) — Cash Flow-to-Debt Ratio
Latest as of December 2024:
-0.02x
NAYA Biosciences, Inc (NAYA) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2024, meaning its operating cash flow of $-617.38K could theoretically repay 0% of its total liabilities ($33.70 Million) in one year. See NAYA Biosciences, Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.02x
Operating CF / Total Liabilities
Operating Cash Flow
$-617.38K
USD
Total Liabilities
$33.70 Million
USD
Data as of
Dec 2024
Most recent filing
NAYA Biosciences, Inc Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for NAYA Biosciences, Inc across 14 annual periods. For the full cash flow conversion analysis, see how efficiently does NAYA Biosciences, Inc generate cash.
Annual Cash Flow-to-Debt Ratio for NAYA Biosciences, Inc (2007–2024)
Year-by-year debt coverage analysis for NAYA Biosciences, Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.09x | $-2.97 Million | $33.70 Million | ▲ +67.3% |
| 2023 | -0.27x | $-4.76 Million | $17.61 Million | ▲ +80.8% |
| 2022 | -1.41x | $-6.60 Million | $4.69 Million | ▲ +26.3% |
| 2021 | -1.91x | $-6.03 Million | $3.16 Million | ▼ -108.3% |
| 2020 | -0.92x | $-4.78 Million | $5.20 Million | ▼ -468.8% |
| 2019 | 0.25x | $1.37 Million | $5.51 Million | ▲ +233.4% |
| 2018 | -0.19x | $-652.97K | $3.50 Million | ▼ -441.0% |
| 2017 | -0.03x | $-181.27K | $5.26 Million | ▲ +47.8% |
| 2016 | -0.07x | $-323.90K | $4.90 Million | ▼ -88.9% |
| 2015 | -0.03x | $-151.62K | $4.34 Million | ▲ +70.5% |
| 2010 | -0.12x | $-315.99K | $2.66 Million | ▲ +54.9% |
| 2009 | -0.26x | $-926.66K | $3.52 Million | ▲ +75.6% |
| 2008 | -1.08x | $-1.07 Million | $988.12K | ▼ -45.8% |
| 2007 | -0.74x | $-116.04K | $156.70K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.